| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.09 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.09 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.09 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.054 | 0.09 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.09 |